EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Remibrutinib demonstrates sustained control of angioedema in patients with chronic spontaneous urticaria: 52-week treatment results from the phase 3 REMIX studies

Saturday 14 Jun, 16:00 PM - 16:12 PM Glasgow, United Kingdom